PHYSIOGENIX, INC.

Company Information

Company Name
PHYSIOGENIX, INC.
Address
PHYSIOGENIX, INC.
10437 INNOVATION DR, STE 325
WAUWATOSA, WI, 53226-4838
Phone
n/a
URL
n/a
DUNS
140323531
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$3,640,066.00
7
SBIR Phase II
$1,510,588.00
2

Award List

  1. Efficacy of GABAA a5 receptor inverse agonists in learning impaired rats

    Amount: $343,796.00

    DESCRIPTION (provided by applicant): The number of patients in the United States afflicted with learning and memory disorders is rapidly increasing. This necessitates the development of new, better a ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. DESIGNER RAT MODELS THAT MIMIC TYPE 2 DIABETES

    Amount: $489,659.00

    This SBIR Phase I project will employ a new bioinformatic tool to combine in silico gene mapping and comparative genomics for predicting designer rat strains that mimic human disease. The genome sequ ...

    SBIR Phase I 2002 Department of Health and Human Services
  3. COMBINATORIAL RAT PANELS FOR PHARMACOGENETIC EFFECTS

    Amount: $100,000.00

    This SBIR Phase I project will create and validate a combinatorial panel of rats designed to detect genetic differences to drug response including toxicity. The genome sequencing projects are bringing ...

    SBIR Phase I 2002 Department of Health and Human Services
  4. Combinatorial rat panels for pharmacogenetic effects

    Amount: $134,425.00

    DESCRIPTION (provided by applicant): The concept of a pre-clinical, drug screen for genetic effects was developed by PhysioGenix in Phase I of this project. The screen consists of inbred rats bred in ...

    SBIR Phase II 2004 Department of Health and Human Services
  5. Combinatorial rat panels that genetically screen anthrax

    Amount: $312,536.00

    DESCRIPTION (provided by applicant): The recent anthrax-related events have revealed the need to fill gaps in the knowledge base that compromise our response to a bioterrorist attack using Category A ...

    SBIR Phase I 2003 Department of Health and Human Services
  6. Identifying drug toxicity signatures using QCarrays

    Amount: $498,610.00

    DESCRIPTION (provided by applicant): This Phase I SBIR project uses a new Quality Control microarray (QCarray) technology to generate Drug Toxicity Signatures (DTSs) for predicting liver toxicity ...

    SBIR Phase I 2004 Department of Health and Human Services
  7. Consomic rat panels for pharmacogenomic studies and target identification

    Amount: $1,644,226.00

    DESCRIPTION (provided by applicant): PhysioGenix plans to commercialize a rat discovery platform that markedly accelerates the deployment of genetic tools for drug development by Pharma. While genetic ...

    SBIR Phase I 2006 Department of Health and Human Services
  8. Molecular fingerprints of alcohol-induced organ damage using new genetic models

    Amount: $251,239.00

    DESCRIPTION (provided by applicant): This SBIR project combines the use of genetic models with genomic, proteomic and metabolomic technologies as a solution to discover molecular fingerprints as bioma ...

    SBIR Phase I 2006 Department of Health and Human Services
  9. Consomic rat panels for pharmacogenomic studies and target identification

    Amount: $1,376,163.00

    Not avaiable.

    SBIR Phase II 2007 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government